In Vermont, Governor Phil Scott signed 16 bills into law while vetoing Senate Bill 190, which proposed reference-based pricing for drugs. The legislation affects state policy on opioid abatement and substance misuse prevention funds, impacting how these resources are allocated.

Supporters argue the bills advance public health and homelessness response, while opponents contest the veto of S.190 and its implications for drug cost control. The governor's office and the Vermont Department of Financial Regulation remain involved in ongoing policy discussions.